Cardiff Oncology Inc (CRDF)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Dr. Thomas H. Adams
Employees:
13
11055 FLINTKOTE AVENUE, SAN DIEGO, CA 92121
858-217-5420

Cardiff Oncology, Inc., a clinical-stage, oncology therapeutic company, develops drugs to treat various types of cancer, including leukemia, lymphomas, and solid tumors.

Data derived from most recent annual or quarterly report
Market Cap 55.432 Million Shares Outstanding43.306 Million Avg 30-day Volume 723.336 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.31
Price to Revenue1026.069 Debt to Equity0.0 EBITDA-18.901 Million
Price to Book Value2.9303 Operating Margin-5214.7541 Enterprise Value244.561 Million
Current Ratio21.794 EPS Growth0.614 Quick Ratio21.458
1 Yr BETA 1.8489 52-week High/Low 8.58 / 1.13 Profit Margin-5275.1366
Operating Cash Flow Growth-22.9697 Altman Z-Score32.5573 Free Cash Flow to Firm -13.421 Million
Earnings Report2022-08-04
View SEC Filings from CRDF instead.

View recent insider trading info

Cardiff Oncology Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CRDF (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRDF BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PACE GARY W

  • Director
 89,574 2022-03-09 3

BRANCACCIO JOHN P

  • Director
 125,317 2022-03-09 2

ARMITAGE JAMES O

  • Director
 89,574 2022-03-09 2

MARKIN RODNEY S

  • Director
 124,627 2022-03-09 2

LEVINE JAMES E. CHIEF FINANCIAL OFFICER

  • Officer
 560,016 2022-03-09 4

TANNENBAUM RENEE P

  • Director
 70,801 2022-03-09 3

WHITE LALE

  • Director
 89,574 2022-03-09 2

ERLANDER MARK CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 1,185,400 2022-03-09 2

MOHINDRU MANI

  • Director
 70,801 2022-03-09 3

KELEMEN VICKI EXEC. VP AND COO

  • Officer
 572,784 2022-03-09 2

RUFFNER KATHERINE L CHIEF MEDICAL OFFICER

  • Officer
 370,016 2022-03-09 3

SMEAL TOD CHIEF SCIENTIFIC OFFICER

  • Officer
 0 2022-01-10 1

ADAMS THOMAS PHD

  • FORMER DIRECTOR
 3,345,090 2021-06-10 1

JACOB GARY S

  • FORMER DIRECTOR
 608,848 2021-06-10 1

RA CAPITAL MANAGEMENT, L.P.

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
 3,290,000 2020-09-30 0

COUNTOURIOTIS ATHENA

  • Director
 0 2019-06-20 0

TENNANT STANLEY

  • Director
 28,839 2018-06-08 0

WELCH WILLIAM J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 842,645 2018-01-30 0

BILLINGS PAUL

  • Director
 0 2018-01-23 0

BRIDGER MANAGEMENT, LLC

MIGNONE ROBERTO

  • 10% Owner
  • FORMER 10% OWNER
No longer subject to file 2016-11-11 0

ZANIBONI STEVE FORMER CFO

  • Officer
 96,968 2016-04-21 0

SCHUH ANTONIUS CEO

  • Officer
  • Director
 0 2016-01-04 0

POSARD MATTHEW L. CHIEF COMMERCIAL OFFICER

  • Officer
 0 2016-01-04 0

FELDBAUM CARL B

  • Director
 0 2015-03-17 0

CERRONE GABRIEL

  • FORMER DIRECTOR
 0 2013-07-26 0

MCGUIGAN CHRISTOPHER

  • Director
 0 2013-02-14 0

HUNTER ROBERT MERRILL

  • 10% Owner
 9,065,004 2012-04-13 0

SHEINERMAN KIRA

  • Director
 1,363,636 2008-06-12 0

POLIAKOFF ABBA DAVID

  • Director
 0 2008-01-03 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CARDIFF ONCOLOGY INC CRDF 2022-05-20 22:15:03 UTC 0.2382 0.5818 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 21:45:03 UTC 0.2448 0.5752 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 21:15:03 UTC 0.2448 0.5752 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 20:45:03 UTC 0.2471 0.5729 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 20:15:05 UTC 0.2471 0.5729 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 19:45:03 UTC 0.2471 0.5729 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 19:15:04 UTC 0.2471 0.5729 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 18:45:03 UTC 0.2471 0.5729 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 18:15:03 UTC 0.2471 0.5729 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 17:45:03 UTC 0.2471 0.5729 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 17:15:03 UTC 0.2471 0.5729 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 16:45:04 UTC 0.2329 0.5871 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 16:15:03 UTC 0.2329 0.5871 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 15:45:03 UTC 0.2329 0.5871 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 15:15:03 UTC 0.2329 0.5871 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 14:45:03 UTC 0.0287 0.7913 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 14:15:04 UTC 0.0287 0.7913 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 13:45:03 UTC 0.0287 0.7913 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 13:15:03 UTC 0.0287 0.7913 1400000
CARDIFF ONCOLOGY INC CRDF 2022-05-20 12:45:03 UTC 0.0287 0.7913 1400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments